Solid Growth Ahead for Carpal Tunnel Release Systems Sector

Neurological disorders are increasing significantly worldwide. Carpal tunnel syndrome (CTS)—a common neurological disorder—is quite prevalent among individuals (its frequence in the general population is estimated to be between 1% and 5%). The syndrome is more common in females with a female-to-male ratio of about three to one. The disease is caused by pressure on the median nerve and requires special tools for treatment, such as carpal tunnel release systems. The development and manufacturing of these tools is one of the major factors anticipated to drive growth of the market in the coming years. Data from Kenneth Research shows the global carpal tunnel release systems market generated $608.6 million in revenue last year and is expected to reach $1.049 billion by the end of 2031, growing 5.7% annually.  

According to the statistics by the Pan American Health Organization (PAHO) of the World Health Organization (WHO), neurological conditions regionwide in 2019 accounted for 533,172 deaths; 60% of those victims (320,043) were women and 40% (213,129) were men. During the same year, 32.9 deaths per 100,000 population (age-standardized) were registered; of those deaths, men accounted for 33.1 deaths per 100,000 population, while women accounted for 32.2 deaths per 100,000 population, the statistics indicated. Moreover, in 2019, neurological disorders accounted for 7.5 million years of life lost (YLLs) and 8.2 million years lived with disability (YLDs).
 
The growth of the global carpal tunnel release systems market can be attributed to the increasing advancements in healthcare, growing R&D expenditures on medical sciences, and the surge in government initiatives that promote research on neurological sciences. According to WHO data, the regional weighted average health gross domestic R&D expenditure (GERD) as a percentage of GDP ranged from 0.01% (Eastern Mediterranean) to 0.07% (Western Pacific), while the median value ranged from 0.01% (South-East Asia) to 0.06% (Europe). On the other hand, the statistics also showed the weighted average health GERD as a percentage of GDP in high-income countries was substantially higher by 0.21% than in other income nations. Besides this, the surge in health expenditure is also expected to contribute to the growth of the market in the coming years. World Bank data indicate the current health expenditure as a share of GDP reached 9.84% in 2019, up from 8.63% in 2000.
 
The global carpal tunnel release systems market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American market generated the largest revenue (234.3 million) last year and is expected to reach $381.9 million by the end of 2031. The market’s growth can primarily be attributed to the presence of a strong healthcare network, the availability of several organizations dedicated neurological sciences, the surge in awareness for advanced medical tools, growing government initiatives to promote healthcare R&D, and the increasing healthcare expenditure in the region. According to World Bank data, the current health expenditure as a share of GDP in North America was 16.32% in 2019, up from 12.2% in 2000. Besides this, a surge in the prevalence of carpal tunnel syndrome in the region is also expected to add to the market growth during the forecast period. American Academy of Family Physicians (AAFP) statistics show the prevalence of carpal tunnel syndrome in the general adult population in North America ranged from 2.7% to 5.8%. Additionally, the mean annual crude incidence of the disease was found to be 329 cases per 100,000 person-years, while the standardized incidence was 276. The North American market is further segmented by country into the United States and Canada. The U.S. market is expected to garner the largest revenue by the end of 2031, while the market in Canada is projected to grow with the highest compound annual growth rate (CAGR) of 6.2%.
 
Europe’s carpal tunnel release systems market generated the second-largest revenue of ($189.9 million) last year and is expected to reach $317.9 million by the end of 2031. This market is segmented by country into Germany, United Kingdom, Italy, France, Russia, Spain, Netherlands, and the Rest of Europe. The U.K. market generated the largest revenue of ($33.2 million) in 2021 and is expected to reach $58.5 million by the end of 2031. Additionally, the Italian market  is projected to grow 6.5% annually.
 
The global carpal tunnel release systems market is segmented on the basis of product into open carpal release systems and endoscopic carpal release systems. The open carpal release systems segment generated the largest revenue last year and is further expected to generate the highest market share by the end of 2031. Additionally, the endoscopic carpal release systems segment is projected to grow with the highest CAGR of 6.4%. In North America, the endoscopic carpal release systems segment is projected to grow with the highest CAGR of 5.9%, whereas in Europe, the open carpal release systems segment is projected to garner the largest revenue of $155.5 million by the end of 2023.
 
The global carpal tunnel release systems market is further segmented by end-use into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals registered the largest revenue ($327.6 million) in 2021 and is expected to reach $546.6 million by the end of 2031. North America generated the largest revenue ($120.4 million) last year and is expected to reach $189.8 million by the end of 2031. Asia Pacific is expected to reach $145 million by the end of 2031, up from $72.8 million in 2021.
 
Some of the prominent industry leaders in the global carpal tunnel release systems market are Stryker Corporation, A.M. Surgical Inc., Arthrex Inc., CONMED Corporation, Integra LifeSciences Corporation, Medical Designs LLC, MicroAire Surgical Instruments LLC, Smith+Nephew plc, Trice Medical, and Sonex Health Inc.